US Patent Issued to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) on Sept. 15 for "PARP inhibitor containing piperazine structure. preparation method therefor and pharmaceutical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,432, issued on Sept. 15, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai).

"PARP inhibitor containing piperazine structure. preparation method therefor and pharmaceutical use thereof" was invented by Yuli Xie (Shanghai), Yongcong Lv (Shanghai), Lihui Qian (Shanghai) and Houxing Fan (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention are a PARP inhibitor containing a piperazine structure, a preparation method therefor and pharmaceutical use thereof. Particularly, the present invention relates to novel compounds of general formulas (1), (2), (3), (4) and (5) and/or a pharmaceutically ...